000			05690cam a2200433Ii 4500
001			96448
003			ES-MaUEC
005			20230102112754.0
006			m o d
007			cr cnu|||unuuu
008			170822s2017 sz o 001 0 eng d
020			_a3319499181 _q(electronic bk.)
020			_a9783319499185 _q(electronic bk.)
020			_z3319499165
020			_z9783319499161 _q(print)
040			_aN$T _beng _erda _epn _cN$T _dGW5XE _dN$T _dEBLCP _dYDX _dOCLCF _dUAB _dAZU _dUPM _dOCLCQ _dMERER _dOCLCQ _dESU _dIOG _dCOO _dES-MaUEC _bspa
050		4	_aRC776.P87 _b2017 EB
245	0	0	_aPulmonary hypertension and interstitial lung disease _cRobert P. Baughman, Roberto G. Carbone, Steven D. Nathan, editors.
250			_aSecond edition.
264		1	_aCham, Switzerland _bSpringer International Publishing _c2017
300			_a1 recurso en línea
336			_aTexto _btxt _2rdacontent
337			_aelectrónico _bc _2rdamedia
338			_arecurso electrónico _bcr _2rdacarrier
347			_atext file _bPDF
505	0		_aDedication; Preface; Acknowledgements; Contents; Contributors; Chapter 1: Radiographic Imaging in Interstitial Lung Disease and Pulmonary Hypertension; Introduction; Pulmonary Hypertension in Interstitial Lung Disease; Chest X-ray in Interstitial Lung Disease with Pulmonary Hypertension; HRCT in IPF with Pulmonary Hypertension; HRCT in NSIP with Pulmonary Hypertension; HRCT in Respiratory Bronchiolitis and Interstitial Lung Disease (RB-ILD); HRCT in Cryptogenic Organizing Pneumonia (COP) with Pulmonary Hypertension.
505	8		_aEvaluation of Vascular Changes in ILDs IPF; Vascular Remodeling and Angiogenesis in IPF; Angiogenic and Angiostatic Imbalance in IPF; Possible Shared Pathogenic Mechanisms between IPF and PH; Influence of Angiogenesis/Vascular Remodeling on Pulmonary Fibrogenesis and Vice Versa; SSc-Associated ILD; Sarcoidosis; Vascular Changes in Pulmonary Sarcoidosis; Vascular Changes in Sarcoidosis-Associated PH; Pulmonary Langerhans Cell Histiocytosis (PLCH); References; Chapter 4: Treatment of Pulmonary Hypertension in Interstitial Lung Disease; Introduction; Rationale to Treat.
505	8		_aHRCT in Acute Interstitial Pneumonia (AIP) with Pulmonary Hypertension HRCT in Desquamative Interstitial Pneumonia (DIP); HRCT in Lymphocytic Interstitial Pneumonia (LIP); HRCT and PH in the Complications of ILD; IPF and Superimposed Acute Thromboembolic Disease; HRCT in Acute Exacerbation of IPF and Pulmonary Hypertension; HRCT in Combined Pulmonary Fibrosis and Pulmonary Emphysema (CPFE); Cardiogenic Pulmonary Edema; Orphan Lung Diseases and Pulmonary Hypertension; Glossary; References; Chapter 2: Invasive Techniques for Diagnosis of PH; Introduction; Methodological Considerations.
505	8		_aMeasurements and Definitions Resting Hemodynamics and Prognosis in PH; PH "Out of Proportion"; Interventions During RHC; Exercise; Fluid Challenge; Vasodilator Challenge; Conclusion; References; Chapter 3: Pathology of Vascular Changes in Interstitial Lung Diseases; Introduction; General Considerations; Normal Microanatomy of the Pulmonary Circulation; Normal Pulmonary Arteries; Normal Pulmonary Veins; Hemodynamic Consequences; Angiogenesis; Vascular Remodeling; Arterial Remodeling; Venous Remodeling; Pathology of Vascular Changes in ILDs.
505	8		_aResults of Prior Studies Selecting the Appropriate Population to Treat; Treatment of Pulmonary Hypertension in Interstitial Lung Disease; Treatment of Pulmonary Hypertension in Sarcoidosis; Future Directions; Conclusion; References; Chapter 5: Lung Transplantation in Interstitial Lung Disease; Overview; Pretransplant Considerations; Timing of Transplant Referral; Comorbidities; Pulmonary Hypertension; Esophageal Dysfunction; Contraindications; Bridge Therapies to Transplant; Operative Considerations; Type of Procedure; Single versus Double Lung Transplant.
520	3		_aThe first edition of this book, published in 2009, was the only book of its kind dedicated exclusively to the diagnosis and management of pulmonary arterial hypertension (PAH) in patients with interstitial lung disease (ILD). Over the past few years, new diagnostic tests and treatments of pulmonary arterial hypertension have been developed and tested. Diagnostic testing has led to more frequent and specific diagnosis in PAH patients, leading to the more widespread use of effective treatment and improved quality of life and reduction of mortality for PAH patients. Pulmonary Hypertension and Interstitial Lung Disease: A Clinical Guide, Second Edition provides an updated and expanded state-of-the-art overview of the problems seen by physicians in the clinical management of ILDs. The first section of the book discusses general features and includes an overview of clinical features, diagnosis and pathology of ILD. The second part discusses specific disorders such as idiopathic pulmonary fibrosis, sarcoidosis, and hypersensitivity pneumonia. Pulmonary Hypertension and Interstitial Lung Disease, Second Edition is an invaluable resource for all physicians whose practice involves the care and treatment of patients with interstitial lung disease.
650		7	_aPulmones _xEnfermedades _2embne _0(OCoLC)fst00977554 _0 _9168957
700	1		_aBaughman, Robert P., _eeditor literario _990286
700	1		_aCarbone, Roberto G., _eeditor literario
700	1		_aNathan, Steven D., _eeditor literario _988397
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=http://link.springer.com/10.1007/978-3-319-49918-5 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
988			_aSpringer_Medicine_2017
998			_b02/2018 _dz _e- _zSI
999			_c96448 _d96448 _x1